The Community Focus Channel is supported with funding from Johnson & Johnson (Gold).
The Myeloproliferative Neoplasms Channel is supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
Texas MPN Workshop 2022 | Key highlights from the 2022 Texas MPN Workshop
In this discussion, Ruben Mesa, MD, UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX, and Naveen Pemmaraju, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, discuss key updates in the treatment and management of myeloproliferative neoplasms (MPNs) at the 2022 Texas MPN Workshop. The experts cover several topics, including advances in the treatment of essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF), ongoing clinical trials in the field, and future outlooks.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
